2020

Messenger RNA is poised to become a major contributor in the fields of gene therapy and vaccines. Making this a practical reality requires purification technology that accommodates its unique features and challenges. Some of those challenges are inherent to mRNA. Others are byproducts of RNA synthesis.

This presentation addresses both and introduces a coordinated purification toolbox to advance the evolution of mRNA therapy.

Attachments

Full view

Presenter: Ingo Nagler

Date: June 3, 2020

Biomanufacturing and Cell & Gene Strategy Meetings (Proventa International's online meetings)

Click here to listen to BIA's Keynote Presentation

Attachments

Full view

Presenter: Ingo Nagler

Date: May 14, 2020

Asia’s SARS-CoV-2 Vaccine Development Challenges (Corona360 In-Conversation webcast series)

Attachments

Full view